[Calciphylaxis]

Knud Bonnet Yderstraede1, Ole Clemmensen, Anna Marie Nielsen

  • 1Odense Universitetshospital, Endokrinologisk Afdeling M, DK - 5000 Odense C. Knud.yderstraede@ouh.regionsyddanmark.dk

Insights

Calciphylaxis, a severe condition affecting patients on chronic hemodialysis, involves tissue necrosis and arterial occlusion. Early intervention and optimized calcium-phosphorus control may prevent this high-mortality disorder.

Area of Science:

  • Vascular Medicine
  • Nephrology
  • Dermatology

Context:

  • Calciphylaxis affects 1-4% of patients undergoing chronic hemodialysis.
  • This condition is characterized by ischemic, nodular necrosis of subcutaneous tissue and vascular occlusion.
  • High mortality rates are linked to co-morbidities in affected patients.

Purpose:

  • To highlight the critical nature of calciphylaxis in hemodialysis patients.
  • To emphasize the potential for prevention through metabolic control.
  • To underscore the need for focused research and therapeutic development.

Summary:

  • Calciphylaxis presents as subcutaneous tissue necrosis and small to medium artery occlusion.
  • Optimizing calcium-phosphorus metabolism is suggested as a preventive strategy.
  • Emerging therapies offer new hope for managing this severe condition.

Impact:

  • Improved patient outcomes through timely diagnosis and treatment.
  • Reduced mortality associated with calciphylaxis.
  • Advancement of therapeutic options for a challenging clinical entity.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
Synthesis and Functions of Calcitonin00:51

Synthesis and Functions of Calcitonin

Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...